Download PDF
October 6, 2020

FDA Will Hold NanoDay Virtual Research Symposium on October 9

Lynn L. Bergeson Carla N. Hutton

The U.S. Food and Drug Administration (FDA) Nanotechnology Task Force is celebrating NanoDay on October 9, 2020, by hosting a virtual research symposium to showcase more than a decade of progress and innovation in nanotechnology at FDA.  The agenda lists the following presentations:

  • A Decade of Progress and Innovation in Nanotechnology at U.S. FDA;
  • Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology;
  • Regulatory Science Research in Nanotechnology;
  • Drug Products That Contain Nanomaterials;
  • Nanotechnology and Medical Devices: A Regulatory Science Approach Involving Research, Standards, and Risk Assessment;
  • Food Ingredients and Food Contact Substances Containing Nanomaterials: Guidance for Manufacturing Process Change;
  • Use of Nanomaterials in Foods and Drugs for Animals;
  • Virtual Tour of the Nanocore Facilities (five-minute video);
  • Biological Products That Contain Nanomaterials;
  • Office of Regulatory Affairs (ORA) and Nanomaterials;
  • Safety of Nanomaterials in Cosmetic Products;
  • Liposome Drug Products Guidance;
  • Standards in Nanotechnology;
  • Collaborative Opportunities for Research Excellence in Science (CORES) Intramural Grants Program; and
  • Highlights of Nanotechnology Research at FDA.

Registration is now open.